Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Keryx Biopharmaceuticals"
Count: 21
Selected: 0
NCT IDTitle
NCT04649411Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
NCT04523727Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
NCT00130312Effect of Sulodexide in Overt Diabetic Nephropathy
NCT03236246KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
NCT02128074A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
NCT00130208Effect of Sulodexide in Early Diabetic Nephropathy
NCT02268994KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
NCT01736397Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
NCT00648167A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
NCT00462202Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
NCT01554982A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
NCT01191255A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
NCT00967993Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
NCT01074125A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
NCT03079869Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
NCT03055598Ferric Citrate in ESRD Pilot Project
NCT02492620Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
NCT00431054Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
NCT02661295A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
NCT00873457Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00590954Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas